Studies on surgical pathology cohorts have reported GNAS mutations in PCF samples in 45–66% of IPMN cases (13,17,18,20,22–25), occasionally in MCN (23–25), and absent in non-mPCNs. Here, GNAS is linked to pancreatic intraductal papillary-mucinous neoplasm.